NEW YORK (GenomeWeb) – Protagen said today that it has received the CE mark for its Multilisa BICD2 test for diagnosing systemic sclerosis, enabling the firm to market the test in the European Union and other countries that accept the CE mark.

The announcement follows the release last month of Protagen's CE-marked Multilisa CENP-B and Multilisa Scl70 assays, giving the company what CEO Stefan Müllner called "a comprehensive assay portfolio for the improvement of [systemic sclerosis] diagnosis and patient care."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.

Oct
10
Sponsored by
PerkinElmer

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.